IL149811A0 - Substituted pyrrole mannich bases to combat pain and allergic reactions - Google Patents
Substituted pyrrole mannich bases to combat pain and allergic reactionsInfo
- Publication number
- IL149811A0 IL149811A0 IL14981100A IL14981100A IL149811A0 IL 149811 A0 IL149811 A0 IL 149811A0 IL 14981100 A IL14981100 A IL 14981100A IL 14981100 A IL14981100 A IL 14981100A IL 149811 A0 IL149811 A0 IL 149811A0
- Authority
- IL
- Israel
- Prior art keywords
- allergic reactions
- mannich bases
- substituted pyrrole
- combat pain
- pyrrole mannich
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19963174A DE19963174A1 (de) | 1999-12-27 | 1999-12-27 | Substituierte Pyrrol-Mannichbasen |
| PCT/EP2000/012976 WO2001047878A1 (de) | 1999-12-27 | 2000-12-20 | Substituierte pyrrol-mannichbasen zur bekämpfung von schmerzen und allergischen reaktionen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL149811A0 true IL149811A0 (en) | 2002-11-10 |
Family
ID=7934619
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14981100A IL149811A0 (en) | 1999-12-27 | 2000-12-20 | Substituted pyrrole mannich bases to combat pain and allergic reactions |
| IL149811A IL149811A (en) | 1999-12-27 | 2004-01-01 | Pirols are transformed as manic bases for the treatment of pain and allergic reactions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL149811A IL149811A (en) | 1999-12-27 | 2004-01-01 | Pirols are transformed as manic bases for the treatment of pain and allergic reactions |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7034018B2 (es) |
| EP (1) | EP1246799B1 (es) |
| JP (1) | JP2003527350A (es) |
| KR (1) | KR20020067571A (es) |
| CN (1) | CN1247542C (es) |
| AR (1) | AR027058A1 (es) |
| AT (1) | ATE252077T1 (es) |
| AU (1) | AU782909B2 (es) |
| BR (1) | BR0016814A (es) |
| CA (1) | CA2396502A1 (es) |
| CO (1) | CO5261489A1 (es) |
| CZ (1) | CZ20022239A3 (es) |
| DE (2) | DE19963174A1 (es) |
| DK (1) | DK1246799T3 (es) |
| ES (1) | ES2208466T3 (es) |
| HU (1) | HUP0203695A3 (es) |
| IL (2) | IL149811A0 (es) |
| MX (1) | MXPA02005793A (es) |
| NO (1) | NO20023028L (es) |
| NZ (1) | NZ519975A (es) |
| PE (1) | PE20010988A1 (es) |
| PL (1) | PL355413A1 (es) |
| PT (1) | PT1246799E (es) |
| RU (1) | RU2002120468A (es) |
| SK (1) | SK286274B6 (es) |
| TR (1) | TR200302178T4 (es) |
| WO (1) | WO2001047878A1 (es) |
| ZA (1) | ZA200204199B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0016453D0 (en) * | 2000-07-04 | 2000-08-23 | Hoffmann La Roche | Pyrrole derivatives |
| CN100406437C (zh) * | 2002-01-11 | 2008-07-30 | 三共株式会社 | 氨基醇衍生物或膦酸衍生物以及含有它们的药物组合物 |
| DE10261130A1 (de) * | 2002-12-20 | 2004-07-01 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2,5-Diaminomethyl-1H-pyrrole |
| EP1836390A2 (en) * | 2004-11-09 | 2007-09-26 | Hendrick Cornelius Van Harsleaar | Electrical system |
| CN102221678A (zh) * | 2011-05-17 | 2011-10-19 | 重庆长安汽车股份有限公司 | 一种电池系统在线寿命计算方法 |
| TW201416348A (zh) * | 2012-08-29 | 2014-05-01 | Gruenenthal Chemie | 以氟甲基取代之吡咯甲醯胺 |
| KR102084185B1 (ko) | 2013-08-29 | 2020-03-04 | 주식회사 대웅제약 | 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4341402A (en) * | 1980-03-06 | 1982-07-27 | Sterling Drug Inc. | Systems employing indole color formers |
| US4335136A (en) | 1980-04-18 | 1982-06-15 | E. I. Du Pont De Nemours And Company | Anti-inflammatory 4,5-diaryl-α-(polyfluoroalkyl)-1H-pyrrole-2-methanamines |
| CA2141791A1 (en) * | 1992-08-06 | 1994-02-17 | Geoffrey Stemp | 5-(2-oxyphenyl)-pyrrole derivatives as dopamine d3 receptor antagonists |
| GB9325827D0 (en) * | 1993-12-17 | 1994-02-23 | Smithkline Beecham Plc | Compounds |
| PT946507E (pt) * | 1996-12-10 | 2004-02-27 | Searle & Co | Compostos de pirrolilo substituidos para o tratamento da inflamacao |
-
1999
- 1999-12-27 DE DE19963174A patent/DE19963174A1/de not_active Ceased
-
2000
- 2000-12-20 IL IL14981100A patent/IL149811A0/xx active IP Right Grant
- 2000-12-20 WO PCT/EP2000/012976 patent/WO2001047878A1/de active Search and Examination
- 2000-12-20 PL PL00355413A patent/PL355413A1/xx unknown
- 2000-12-20 JP JP2001549351A patent/JP2003527350A/ja not_active Withdrawn
- 2000-12-20 HU HU0203695A patent/HUP0203695A3/hu unknown
- 2000-12-20 TR TR2003/02178T patent/TR200302178T4/xx unknown
- 2000-12-20 PT PT00991220T patent/PT1246799E/pt unknown
- 2000-12-20 ES ES00991220T patent/ES2208466T3/es not_active Expired - Lifetime
- 2000-12-20 NZ NZ519975A patent/NZ519975A/en unknown
- 2000-12-20 CN CNB008178739A patent/CN1247542C/zh not_active Expired - Fee Related
- 2000-12-20 RU RU2002120468/04A patent/RU2002120468A/ru unknown
- 2000-12-20 CZ CZ20022239A patent/CZ20022239A3/cs unknown
- 2000-12-20 KR KR1020027008185A patent/KR20020067571A/ko not_active Withdrawn
- 2000-12-20 CA CA002396502A patent/CA2396502A1/en not_active Abandoned
- 2000-12-20 MX MXPA02005793A patent/MXPA02005793A/es active IP Right Grant
- 2000-12-20 BR BR0016814-9A patent/BR0016814A/pt not_active Application Discontinuation
- 2000-12-20 EP EP00991220A patent/EP1246799B1/de not_active Expired - Lifetime
- 2000-12-20 SK SK730-2002A patent/SK286274B6/sk not_active IP Right Cessation
- 2000-12-20 AT AT00991220T patent/ATE252077T1/de active
- 2000-12-20 US US10/168,964 patent/US7034018B2/en not_active Expired - Fee Related
- 2000-12-20 AU AU31611/01A patent/AU782909B2/en not_active Ceased
- 2000-12-20 DK DK00991220T patent/DK1246799T3/da active
- 2000-12-20 DE DE50004114T patent/DE50004114D1/de not_active Expired - Lifetime
- 2000-12-21 AR ARP000106837A patent/AR027058A1/es unknown
- 2000-12-22 CO CO00097382A patent/CO5261489A1/es not_active Application Discontinuation
- 2000-12-26 PE PE2000001398A patent/PE20010988A1/es not_active Application Discontinuation
-
2002
- 2002-05-27 ZA ZA200204199A patent/ZA200204199B/en unknown
- 2002-06-21 NO NO20023028A patent/NO20023028L/no not_active Application Discontinuation
-
2004
- 2004-01-01 IL IL149811A patent/IL149811A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2000001983A0 (en) | Antibodies to cd23 derivatives thereof and their therapeutic uses | |
| GB9919681D0 (en) | Improvements relating to medical injectors and skin prickers | |
| HUP0300746A3 (en) | Proline derivatives and use thereof as drugs | |
| HRP20060251B1 (hr) | Supstituirani oksazolidinoni i njihova uporaba | |
| AU7166698A (en) | Internal magnetic device to enhance drug therapy | |
| IL126638A0 (en) | Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals | |
| MXPA02004770A (es) | Composiciones terapeuticas y metodos para su uso. | |
| GB2353612B (en) | Processing by use of synchronised tuple spaces and assertions | |
| IL116139A0 (en) | Pyrrole derivatives their preparation and use | |
| AU3931400A (en) | N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators | |
| HU0002846D0 (en) | Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses | |
| EP1235785A4 (en) | NEW CONNECTIONS FOR THE TREATMENT OF DIABETES AND ASSOCIATED DISEASES | |
| IL149811A0 (en) | Substituted pyrrole mannich bases to combat pain and allergic reactions | |
| ZA9711168B (en) | New therapeutic application of pyrrole derivatives. | |
| ZA9811346B (en) | Substituted heterocyclic benzocycloalkenes and their use as an analgesic | |
| EP1181374A4 (en) | NEW HUMAN AND MURINE KINASES | |
| IL146465A0 (en) | Substituted 3-pyridyl-4-arylpyrroles and related therapeutic and prophylactic methods | |
| SI1246799T1 (en) | Substituted pyrrole mannich bases to combat pain and allergic reactions | |
| EG23054A (en) | Pyrrole derivatives their preparation and their therapeutic uses | |
| GB9919030D0 (en) | Engine with controllable auto-ignition | |
| GB9919031D0 (en) | Engine with controlled auto-ignition | |
| AU4332900A (en) | Use of interleukin-11 to treat gastrointestinal disorders | |
| GB9903919D0 (en) | Aminophenols and their therapeutic use | |
| HU9900334V0 (en) | Internal door-structure made of timber-arch | |
| HU9902379D0 (en) | Firering and dust-separator apparatous to utilize plant-wastes by air-protecting way |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed |